Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat 80 mg bioequivalence study in healthy Thai volunteers under fasting conditions
TCTR20250112012Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of febuxostat in hyperuricemia (3 arms), sponsored by Bio-innova. Primary endpoint: Blood febuxostat concentrations. Status: unknown.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on TCTR20250112012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250112012.